Cenata GmbH | Paul-Ehrlich-Str. 23 | D-72076 Tübingen | Tel. 07071 – 565 44 430 | Fax 07071 – 565 44 444

header-harmony-logo

Cenata GmbH | Paul-Ehrlich-Str. 23 | D-72076 Tübingen | Tel. 07071 – 565 44 430 | Fax 07071 – 565 44 444

Home

Fast,
accurate result
Result within an average
of 3 business days
ALLE INFORMATIONENE HIER
Excellent
detection rate
>99% detection rate for trisomy 21
in published studies
ALLE INFORMATIONEN HIER
Low
false-positive rate
Only 0.06% for trisomy 21
ALLE INFORMATIONEN HIER
Highly qualified medical
team for diagnosis
and advice
ALLE INFORMATIONEN HIER
Previous slide
Next slide

For physicians

For expectant parents

For physicians

For expectant parents

The Harmony® Test

header-harmony-logo

The Harmony® Test can reliably detect the risk of the chromosomal disorders trisomy 21trisomy 18trisomy 13 as well as X- and Y-chromosomal disorders. All aspects of the Harmony® Test are carried out according to european standards of quality and data protection.

Expert opinions on non-invasive prenatal screening test (NIPT)

 

Performing Harmony® Test

Advantages of the Harmony® Test

Excellent detection rate for trisomy 21, 18 and 13

Very low false-positive rate

Fast turnaround time

Excellent clinical validation in studies with more than 270.000 patients

Affordable price

Feasibility under heparin treatment

Latest News

Improved version of the Harmony® test now in use

By optimizing the laboratory process, we were able to significantly reduce the failure rate of the Harmony® test. An NIPT without a result often causes uncertainty among pregnant women and in many cases leads to further – usually invasive – clarification. A low rate of non-evaluable tests is therefore an important quality criteria for a

Read more »

Latest publication: Screen-positive rate in cell-free DNA screening for microdeletion 22q11.2

In a recent study, published in February 2023 in Prenatal Diagnosis, we investigated in collaboration with Prof. Kagan (University Women’s Hospital Tuebingen) the correlation between the screen-positive rate and the fetal fraction (proportion of cell-free fetal DNA) when screening for microdeletion 22q11.2 (DiGeorge syndrome). We analyzed own data from more than 50,000 singleton pregnancies. The

Read more »

The Harmony® Test

header-harmony-logo

The Harmony® Test can reliably detect the risk of the chromosomal disorders trisomy 21trisomy 18trisomy 13 as well as X- and Y-chromosomal disorders. All aspects of the Harmony® Test are carried out according to european standards of quality and data protection.

Expert opinions on non-invasive prenatal screening test (NIPT)

Durchführung Harmony Test

Advantages of the Harmony® Test

Excellent detection rate for trisomy 21, 18 and 13

Very low false-positive rate

Fast turnaround time

Excellent clinical validation in studies with more than 270.000 patients

Affordable price

Feasibility under heparin treatment

Latest News

Improved version of the Harmony® test now in use

By optimizing the laboratory process, we were able to significantly reduce the failure rate of the Harmony® test. An NIPT without a result often causes uncertainty among pregnant women and in many cases leads to further – usually invasive – clarification. A low rate of non-evaluable tests is therefore an important quality criteria for a

Read more »

Latest publication: Screen-positive rate in cell-free DNA screening for microdeletion 22q11.2

In a recent study, published in February 2023 in Prenatal Diagnosis, we investigated in collaboration with Prof. Kagan (University Women’s Hospital Tuebingen) the correlation between the screen-positive rate and the fetal fraction (proportion of cell-free fetal DNA) when screening for microdeletion 22q11.2 (DiGeorge syndrome). We analyzed own data from more than 50,000 singleton pregnancies. The

Read more »

The Harmony® Test

header-harmony-logo

The Harmony® Test can reliably detect the risk of the chromosomal disorders trisomy 21trisomy 18trisomy 13 as well as X- and Y-chromosomal disorders. All aspects of the Harmony® Test are carried out according to european standards of quality and data protection.

Expert opinions on non-invasive prenatal screening test (NIPT)

Durchführung Harmony Test

Advantages of the Harmony® Test

Excellent detection rate for trisomy 21, 18 and 13

Very low false-positive rate

Fast turnaround time

Excellent clinical validation in studies with more than 270.000 patients

Affordable price

Feasibility under heparin treatment

Latest News

Improved version of the Harmony® test now in use

By optimizing the laboratory process, we were able to significantly reduce the failure rate of the Harmony® test. An NIPT without a result often causes uncertainty among pregnant women and in many cases leads to further – usually invasive – clarification. A low rate of non-evaluable tests is therefore an important quality criteria for a

Read more »

Latest publication: Screen-positive rate in cell-free DNA screening for microdeletion 22q11.2

In a recent study, published in February 2023 in Prenatal Diagnosis, we investigated in collaboration with Prof. Kagan (University Women’s Hospital Tuebingen) the correlation between the screen-positive rate and the fetal fraction (proportion of cell-free fetal DNA) when screening for microdeletion 22q11.2 (DiGeorge syndrome). We analyzed own data from more than 50,000 singleton pregnancies. The

Read more »

Procedure of the Harmony® Test

Icon - Beratung

Genetic counseling

Patient requests the Harmony® Test and gets a genetic counseling by obstetrician or human geneticist

Icon - Anforderungsformular und Blutabnahme

Blood sample

Blood sample is taken and the order form is filled out by physician and patient
Icon - Anforderungsformular + Blut + Kit

Shipping

Blood sample and order form are sent
Icon – Testdurchführung und Befund

Test performance

Test is carried out, data is analyzed and the findings are compiled
Icon - Beratung & Befund

Receipt of report

Physician reports the findings to the patient including genetic counseling
Scroll to Top
Scroll to Top